Table 2.
Values on measures amongst participants in the observation phase at each time point
| Outcome | Baseline | 3 weeks | 12 weeks/3 months | |||
|---|---|---|---|---|---|---|
| M (SD) | Median (range) | M (SD) | Median (range) | M (SD) | Median (range) | |
| Performance-based | ||||||
| Grip strength (Kg) | ||||||
| Right | 17 (12.4) | 18 (13.7) | ||||
| Left | 14 (11.4) | 12 (12.3) | ||||
| 10-m walk test (s) | 41 (28.4) | 52 (52.7) | ||||
| MoCA | 14 (6.2) | 13 (4–26) | 17 (4.8) | 18 (7–25) | ||
| BI | 11 (4.5) | 10 (4–20) | 11 (3.5) | 11 (6–17) | ||
| Self-report | ||||||
| FSS | 43 (15–63) | 51 (11–61) | ||||
| VAF-S | 6 (0–10) | 7 (2–10) | ||||
| EQ-5D-5L VAS | 57 (26.2) | 60 (10–100) | 59 (26.8) | 65 (0–100) | 56 (16.5) | 60 (30–85) |
| RMI | 6 (1–14) | 8 (1–12) | 9 (0–15) | |||
| WHODAS | 45 (18–83) | 53 (33–77) | 44 (12–100) | |||
Data were included only if the patient successfully completed assessment.
Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item). M (SD), mean and standard deviation. WHODAS scores represent a percentage of the maximum disability score (the total score, between 0 and 48, is divided by 48 and multiplied by 100)